Humacyte, Inc.HUMANASDAQ
LOADING
|||
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-132.23M
↓ 55% below average
Average (5y)
$-85.54M
Historical baseline
Range
High:$-56.25M
Low:$-132.23M
CAGR
+10.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-132.23M | -37.1% |
| 2023 | $-96.46M | -26.3% |
| 2022 | $-76.37M | -4.7% |
| 2021 | $-72.97M | -29.7% |
| 2020 | $-56.25M | +28.7% |
| 2019 | $-78.94M | - |